Nova saw its IBD SmartSelect Composite Rating rise to 98 Thursday, up from 94 the day before.
Looking For Winning Stocks? How To Invest In Both Bull And Bear Markets
The revised score means the stock currently tops 98% of all other stocks in terms of key performance metrics and technical strength. Winning stocks often have a 95 or higher score in the early stages of a new price run, so that's a good item to have on your checklist when looking for the best stocks to buy and watch.
Nova is not currently near a proper entry. See if the stock goes on to form a new chart pattern and offer a new buying opportunity.
The stock earns a 99 EPS Rating, meaning its recent quarterly and annual earnings growth tops 99% of all stocks.
Its Accumulation/Distribution Rating of B shows moderate buying by institutional investors over the last 13 weeks.
The company reported 57% EPS growth for Q1. That marks two straight reports with rising EPS performance. Sales growth climbed 50%, up from 45% in the prior report. That marks five quarters of rising growth.
Nova holds the No. 2 rank among its peers in the Electronics-Semiconductor Equipment industry group. KLA is the top-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
